Comprehensive handbook for developing a bladder cancer cystectomy database.

[1]  M. Mi,et al.  Flavonoids, Flavonoid Subclasses and Breast Cancer Risk: A Meta-Analysis of Epidemiologic Studies , 2013, PloS one.

[2]  L. Kiemeney,et al.  Discrepancy between clinical staging through bimanual palpation and pathological staging after cystectomy. , 2012, Urologic oncology.

[3]  M. Khochikar.  EARLY VS DELAYED RADICAL CYSTECTOMY FOR ‘HIGH‐RISK’ CARCINOMA NOT INVADING BLADDER MUSCLE: DELAY OF CYSTECTOMY REDUCES CANCER‐SPECIFIC SURVIVAL , 2011, BJU international.

[4]  Y. Lotan,et al.  Management of elderly patients with urothelial carcinoma of the bladder: guideline concordance and predictors of overall survival , 2010, BJU international.

[5]  W. Sexton,et al.  Bladder cancer: a review of non-muscle invasive disease. , 2010, Cancer control : journal of the Moffitt Cancer Center.

[6]  A. Jemal,et al.  Cancer Statistics, 2010 , 2010, CA: a cancer journal for clinicians.

[7]  J. Kaouk,et al.  Surgical margin status after robot assisted radical cystectomy: results from the International Robotic Cystectomy Consortium. , 2010, The Journal of urology.

[8]  J. Epstein.  Diagnosis and Classification of Flat, Papillary, and Invasive Urothelial Carcinoma: The WHO/ISUP Consensus , 2010, International journal of surgical pathology.

[9]  Sanjay G. Patel,et al.  Preoperative hydronephrosis predicts extravesical and node positive disease in patients undergoing cystectomy for bladder cancer. , 2010, The Journal of urology.

[10]  U. Capitanio,et al.  International validation of the prognostic value of lymphovascular invasion in patients treated with radical cystectomy , 2010, BJU international.

[11]  U. Capitanio,et al.  Soft tissue surgical margin status is a powerful predictor of outcomes after radical cystectomy: a multicenter study of more than 4,400 patients. , 2009, The Journal of urology.

[12]  A. Shabsigh,et al.  Analysis of gender differences in early perioperative complications following radical cystectomy at a tertiary cancer center using a standardized reporting methodology. , 2010, Urologic oncology.

[13]  Y. Lotan,et al.  Perioperative intravesical therapy after transurethral resection for bladder cancer. , 2010, The Journal of urology.

[14]  A. Bohle.  An individual patient data meta-analysis of the long-term outcome of randomised studies comparing intravesical mitomycin C versus bacillus Calmette-Guérin for non-muscle-invasive bladder cancer , 2009 .

[15]  P. Fayers,et al.  Quality of life and body image for bladder cancer patients undergoing radical cystectomy and urinary diversion--a prospective cohort study with a systematic review of literature. , 2009, Urology.

[16]  G. Ergun,et al.  Prognostic Significance of Hydronephrosis in Bladder Cancer Treated by Radical Cystectomy , 2009, Urologia Internationalis.

[17]  R. Bahnson,et al.  Preoperative hydronephrosis as an indicator of survival after radical cystectomy. , 2009, Urologic oncology.

[18]  R. Autorino,et al.  Health related quality of life after radical cystectomy: comparison of ileal conduit to continent orthotopic neobladder. , 2009, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[19]  J. Witjes,et al.  An individual patient data meta-analysis of the long-term outcome of randomised studies comparing intravesical mitomycin C versus bacillus Calmette-Guérin for non-muscle-invasive bladder cancer. , 2009, European urology.

[20]  P. Javlé,et al.  Orthotopic neobladder versus ileal conduit urinary diversion after cystectomy--a quality-of-life based comparison. , 2009, Annals of the Royal College of Surgeons of England.

[21]  B. Konety,et al.  The significance of lymphovascular invasion in transurethral resection of bladder tumour and cystectomy specimens on the survival of patients with urothelial bladder cancer , 2009, BJU international.

[22]  B. Bochner,et al.  Defining early morbidity of radical cystectomy for patients with bladder cancer using a standardized reporting methodology. , 2009, European urology.

[23]  S. Baltacı,et al.  Computerized Tomography for Detecting Perivesical Infiltration and Lymph Node Metastasis in Invasive Bladder Carcinoma , 2008, Urologia Internationalis.

[24]  H. Herr,et al.  Quality control in transurethral resection of bladder tumours , 2008, BJU international.

[25]  J. Montie,et al.  Lymphovascular invasion of urothelial cancer in matched transurethral bladder tumor resection and radical cystectomy specimens. , 2008, The Journal of urology.

[26]  H. Herr.  Is maintenance Bacillus Calmette-Guérin really necessary? , 2008, European urology.

[27]  T. Guzzo,et al.  Hydronephrosis is an independent predictor of poor clinical outcome in patients treated for muscle-invasive transitional cell carcinoma with radical cystectomy. , 2008, Urology.

[28]  A. Vickers,et al.  Age‐adjusted Charlson comorbidity score is associated with treatment decisions and clinical outcomes for patients undergoing radical cystectomy for bladder cancer , 2008, Cancer.

[29]  A. Tizzani,et al.  Morbidity and quality of life in elderly patients receiving ileal conduit or orthotopic neobladder after radical cystectomy for invasive bladder cancer. , 2008, Urology.

[30]  J. Witjes,et al.  Comparison of three schedules of intravesical epirubicin in patients with non-muscle-invasive bladder cancer. , 2008, European urology.

[31]  L. Elting,et al.  Gender and age differences in blood utilization and length of stay in radical cystectomy: a population-based study , 2008, International Urology and Nephrology.

[32]  Y. Lotan,et al.  Outcomes of patients with clinical T1 grade 3 urothelial cell bladder carcinoma treated with radical cystectomy. , 2008, Urology.

[33]  H. Hricak,et al.  Bladder cancer: can imaging change patient management? , 2008, Current opinion in urology.

[34]  B. Konety,et al.  A DELAY IN RADICAL CYSTECTOMY OF >3 MONTHS IS NOT ASSOCIATED WITH A WORSE CLINICAL OUTCOME , 2007, BJU international.

[35]  Kevin C Zorn,et al.  The Will Rogers phenomenon in urological oncology. , 2008, The Journal of urology.

[36]  K. Kavanagh,et al.  Positive surgical margins in soft tissue following radical cystectomy for bladder cancer and cancer specific survival. , 2007, The Journal of urology.

[37]  A. Zlotta.  When and how to treat superficial and muscle-invasive bladder cancer. , 2007, European urology.

[38]  C. Dinney,et al.  P0 stage at radical cystectomy for bladder cancer is associated with improved outcome independent of traditional clinical risk factors. , 2007, European urology.

[39]  E. Wallen,et al.  Incidence and risk factors of stomal complications in patients undergoing cystectomy with ileal conduit urinary diversion for bladder cancer. , 2007, The Journal of urology.

[40]  C. Klabunde,et al.  A refined comorbidity measurement algorithm for claims-based studies of breast, prostate, colorectal, and lung cancer patients. , 2007, Annals of epidemiology.

[41]  M. Tinetti,et al.  The impact of chronic illnesses on the use and effectiveness of adjuvant chemotherapy for colon cancer , 2007, Cancer.

[42]  W. See.  Postoperative nomogram predicting risk of recurrence after radical cystectomy for bladder cancer , 2007 .

[43]  John T. Wei,et al.  Measuring health‐related quality of life outcomes in bladder cancer patients using the Bladder Cancer Index (BCI) , 2007, Cancer.

[44]  N. Holalkere,et al.  State-of-the-art cross-sectional imaging in bladder cancer. , 2007, Current problems in diagnostic radiology.

[45]  J. Wright,et al.  Quality-of-life assessment in patients with bladder cancer , 2007, Nature Clinical Practice Urology.

[46]  R. Kuefer,et al.  Hydronephrosis as a prognostic marker in bladder cancer in a cystectomy-only series. , 2007, European urology.

[47]  S. Donat.  Standards for surgical complication reporting in urologic oncology: time for a change. , 2007, Urology.

[48]  J. Stein,et al.  Surgical benchmarks for the treatment of invasive bladder cancer. , 2007, Urologic oncology.

[49]  Jingbo Zhang,et al.  Imaging of bladder cancer. , 2007, Radiologic clinics of North America.

[50]  A. Jemal,et al.  Cancer Statistics, 2007 , 2007, CA: a cancer journal for clinicians.

[51]  Yair Lotan,et al.  Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium. , 2006, The Journal of urology.

[52]  Y. Lotan,et al.  Precystectomy nomogram for prediction of advanced bladder cancer stage. , 2006, European urology.

[53]  A. Vickers,et al.  Standardization of pelvic lymphadenectomy performed at radical cystectomy , 2006, Cancer.

[54]  Yair Lotan,et al.  Nomogram for predicting disease recurrence after radical cystectomy for transitional cell carcinoma of the bladder. , 2006, The Journal of urology.

[55]  Núria Malats,et al.  Smoking and Bladder Cancer in Spain: Effects of Tobacco Type, Timing, Environmental Tobacco Smoke, and Gender , 2006, Cancer Epidemiology Biomarkers & Prevention.

[56]  R. Dunn,et al.  Cystectomy delay more than 3 months from initial bladder cancer diagnosis results in decreased disease specific and overall survival. , 2006, The Journal of urology.

[57]  J. Thüroff,et al.  Lymph Node Metastases in Non-Muscle Invasive Bladder Cancer are Correlated With the Number of Transurethral Resections and Tumour Upstaging at Radical Cystectomy , 2006 .

[58]  S. Joniau,et al.  Clinical experience with the N-shaped ileal neobladder: assessment of complications, voiding patterns, and quality of life in our series of 58 patients. , 2006, European urology.

[59]  K. Shigeno,et al.  Health related quality of life after orthotopic neobladder construction and its comparison with normative values in the Japanese population. , 2005, The Journal of urology.

[60]  R. Havlik,et al.  Age and comorbidity impact surgical therapy in older bladder carcinoma patients , 2005, Cancer.

[61]  Yair Lotan,et al.  Lymphovascular Invasion Is Independently Associated With Overall Survival, Cause-Specific Survival, and Local and Distant Recurrence in Patients With Negative Lymph Nodes at Radical Cystectomy , 2005 .

[62]  C. Vale.  Neoadjuvant Chemotherapy in Invasive Bladder Cancer: Update of a Systematic Review and Meta-Analysis of Individual Patient Data: Advanced Bladder Cancer (ABC) Meta-analysis Collaboration , 2005 .

[63]  M. Parmar,et al.  Adjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis of individual patient data Advanced Bladder Cancer (ABC) Meta-analysis Collaboration. , 2005, European urology.

[64]  J. Witjes,et al.  Bacillus calmette-guerin versus chemotherapy for the intravesical treatment of patients with carcinoma in situ of the bladder: a meta-analysis of the published results of randomized clinical trials. , 2005, The Journal of urology.

[65]  S. Joniau,et al.  Clinical Experience with the N-shaped Ileal Neobladder: Assessment of Complications, Voiding Patterns, and Quality of Life in Our Series of 58 Patients , 2005 .

[66]  V. Ficarra,et al.  Correlation between clinical and pathological staging in a series of radical cystectomies for bladder carcinoma , 2005, BJU international.

[67]  K. Yoshimura,et al.  Impact of superficial bladder cancer and transurethral resection on general health-related quality of life: an SF-36 survey. , 2005, Urology.

[68]  S. Almenar,et al.  The optimum timing of radical cystectomy for patients with recurrent high‐risk superficial bladder tumour , 2004, BJU international.

[69]  N. Demartines,et al.  Classification of Surgical Complications: A New Proposal With Evaluation in a Cohort of 6336 Patients and Results of a Survey , 2004, Annals of Surgery.

[70]  H. Grossman,et al.  Surgical factors influence bladder cancer outcomes: a cooperative group report. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[71]  R. Sylvester,et al.  A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: a meta-analysis of published results of randomized clinical trials. , 2004, The Journal of urology.

[72]  Sam S. Chang,et al.  Standardization of radical cystectomy and pelvic lymph node dissection for bladder cancer: a collaborative group report. , 2004, The Journal of urology.

[73]  F. Montorsi,et al.  Overall clinical outcomes after nerve and seminal sparing radical cystectomy for the treatment of organ confined bladder cancer. , 2004, The Journal of urology.

[74]  Gerhard Jakse,et al.  A second-look TUR in T1 transitional cell carcinoma: why? , 2004, European urology.

[75]  Kathryn E. McGoldrick,et al.  Surgeon Volume and Operative Mortality in the United States , 2004 .

[76]  A. Böhle,et al.  Intravesical bacille Calmette-Guérin versus mitomycin C in superficial bladder cancer: formal meta-analysis of comparative studies on tumor progression. , 2004, Urology.

[77]  R. Sylvester,et al.  478 One immediate postoperative instillation of chemotherapy reduces the risk of recurrence in patients with stage TA T1 bladder cancer: A meta-analysis of the published results of randomized clinical trials , 2004 .

[78]  J. Overgaard,et al.  Early and late treatment‐related morbidity following radical cystectomy , 2004, Scandinavian journal of urology and nephrology.

[79]  M. Ghoneim,et al.  Secondary malignant involvement of gynecologic organs in radical cystectomy specimens in women: is it mandatory to remove these organs routinely? , 2003, The Journal of urology.

[80]  A. Seraji,et al.  A comparison between clinical and pathologic staging in patients with bladder cancer. , 2004, Urology journal.

[81]  Liang Cheng,et al.  Stage pT1 bladder carcinoma: diagnostic criteria, pitfalls and prognostic significance. , 2003, Pathology.

[82]  Sam S. Chang,et al.  Health related quality of life in patients treated with radical cystectomy and urinary diversion for urothelial carcinoma of the bladder: development and validation of a new disease specific questionnaire. , 2003, The Journal of urology.

[83]  Sam S. Chang,et al.  Delaying radical cystectomy for muscle invasive bladder cancer results in worse pathological stage. , 2003, The Journal of urology.

[84]  P. Grosclaude,et al.  Determinants of quality of life of bladder cancer survivors five years after treatment in France , 2003, International journal of urology : official journal of the Japanese Urological Association.

[85]  Badrinath R Konety,et al.  Extent of pelvic lymphadenectomy and its impact on outcome in patients diagnosed with bladder cancer: analysis of data from the Surveillance, Epidemiology and End Results Program data base. , 2003, The Journal of urology.

[86]  W. Huang,et al.  An interval longer than 12 weeks between the diagnosis of muscle invasion and cystectomy is associated with worse outcome in bladder carcinoma. , 2003, The Journal of urology.

[87]  Sam S. Chang,et al.  Complications of radical cystectomy for nonmuscle invasive disease: comparison with muscle invasive disease. , 2003, The Journal of urology.

[88]  A. Böhle,et al.  Intravesical bacillus Calmette-Guerin versus mitomycin C for superficial bladder cancer: a formal meta-analysis of comparative studies on recurrence and toxicity. , 2003, The Journal of urology.

[89]  V. Reuter,et al.  Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer. , 2003, The Journal of urology.

[90]  B. Guillonneau,et al.  Cystectomy with prostate sparing for bladder cancer in 100 patients: 10-year experience. , 2002, The Journal of urology.

[91]  D. Lamm,et al.  Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials. , 2002, The Journal of urology.

[92]  J. Birkmeyer,et al.  Hospital volume and surgical mortality in the United States. , 2002, The New England journal of medicine.

[93]  Robert C. G. Martin,et al.  Quality of Complication Reporting in the Surgical Literature , 2002, Annals of surgery.

[94]  Sam S. Chang,et al.  Analysis of early complications after radical cystectomy: results of a collaborative care pathway. , 2002, The Journal of urology.

[95]  H. Miyake,et al.  Health‐related quality of life after radical cystectomy for bladder cancer: a comparison of ileal conduit and orthotopic bladder replacement , 2002, BJU international.

[96]  H. Miyake,et al.  Health-related quality of life after radical cystectomy for bladder cancer: a comparison of ileal conduit and orthotopic bladder replacement , 2002 .

[97]  S. Groshen,et al.  Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[98]  J L Warren,et al.  Development of a comorbidity index using physician claims data. , 2000, Journal of clinical epidemiology.

[99]  G. Bartsch,et al.  Quality of life after cystectomy and orthotopic neobladder versus ileal conduit urinary diversion , 2000, World Journal of Urology.

[100]  E Dorant,et al.  The impact of characteristics of cigarette smoking on urinary tract cancer risk , 2000, Cancer.

[101]  M. Resnick,et al.  Limitations of computerized tomography in staging invasive bladder cancer before radical cystectomy. , 2000, The Journal of urology.

[102]  D. Lamm,et al.  Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study. , 2000, The Journal of urology.

[103]  D J Rosario,et al.  The changing pattern of mortality and morbidity from radical cystectomy , 2000, BJU international.

[104]  Lawrence D. True,et al.  The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder , 1998 .

[105]  M. Droller,et al.  Bladder cancer: State‐of‐the‐art care , 1998, CA: a cancer journal for clinicians.

[106]  F. Mostofi,et al.  The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. , 1998, The American journal of surgical pathology.

[107]  Luc Bijnens,et al.  A combined analysis of European Organization for Research and Treatment of Cancer and Medical Research Council randomized clinical trials for the prophylactic treatment of stage TaT1 bladder cancer , 1996 .

[108]  S. Fosså,et al.  Clinical significance of routine pre-cystectomy bone scans in patients with muscle-invasive bladder cancer. , 1996, British journal of urology.

[109]  W. Fair,et al.  Intravesical bacillus Calmette-Guérin therapy prevents tumor progression and death from superficial bladder cancer: ten-year follow-up of a prospective randomized trial. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[110]  J. Barentsz,et al.  Staging urinary bladder cancer: value of T1-weighted three-dimensional magnetization prepared-rapid gradient-echo and two-dimensional spin-echo sequences. , 1995, AJR. American journal of roentgenology.

[111]  D. Tulsky,et al.  The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[112]  R. Deyo,et al.  Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. , 1992, Journal of clinical epidemiology.

[113]  C. Sherbourne,et al.  The MOS 36-Item Short-Form Health Survey (SF-36) , 1992 .

[114]  J. Sanabria,et al.  Proposed classification of complications of surgery with examples of utility in cholecystectomy. , 1992, Surgery.

[115]  J. Dunn,et al.  Neo-adjuvant (pre-emptive) cisplatin therapy in invasive transitional cell carcinoma of the bladder. , 1991, British journal of urology.

[116]  F. Marshall,et al.  Local recurrence and survival following nerve-sparing radical cystoprostatectomy. , 1990, The Journal of urology.

[117]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.

[118]  Gregory Spencer,et al.  Projections of the Population of the United States, by Age, Sex, and Race: 1983 to 2080. , 1984 .